9/23/2026
Psyence BioMed announces ibogaine investment and trial plans
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
Topic archive
psyence labs ltd.
4 stories
9/23/2026
Psyence Biomedical expands with Texas ibogaine unit
Company invests $5 million in PsyLabs for ibogaine research and production.
9/23/2026
Psyence BioMed invests $5M in PsyLabs for U.S. ibogaine program
Investment aims to bolster ibogaine research for opioid use disorder in Texas.
9/23/2026
Psyence and PsyLabs share exchange to boost ibogaine research
Psyence and PsyLabs collaborate to advance ibogaine for opioid use disorder.